Point-Of-Care Diagnostics Market

Point-Of-Care Diagnostics Market Size, Share & Trends Analysis Report

Point-Of-Care Diagnostics Market Size, Share, Companies & Trends Analysis Report By Testing (Glucose Testing, Infectious Disease, Blood Gas Electrolyte, Cardiac Biomarker, Coagulation, Cholesterol, Pregnancy, Others), By Mode (Prescription-Based Testing, OTC-Based Testing), By End-Users (Hospitals And Clinics, Homecare Settings, Diagnostic Centers), Industry Analysis, Trends, And Forecast, 2022-2028

Report ID : BMRC 234
Number of pages : 300
Published Date : May 2023
Category : Healthcare
Delivery Timeline : 48 hrs

Point-of-Care Diagnostics Market is valued at USD 22688.6 Million in 2018 and expected to reach USD 46308.9 Million by 2025 with the CAGR of 10.73% over the forecast period. Increasing prevalence of infectious diseases across the world and changing healthcare practice environment is expected to drive the point-of-care diagnostics market growth.

Point-of-care testing diagnostics (POCD) refers to the rapid detection of diseases near to patient, which provides an appropriate diagnosis, monitoring and management. Potentially it offers fast medical treatment to improve health outcome of patients to cure medical conditions. Consequently, POCD can be integrated with healthcare system to provide laboratory testing outside of the main laboratory with dedicated clinical settings. Recent advancements in point of care diagnostics have made testing easier that can be performed by moderately trained staff and require less human interaction. For example, sensor technologies is used to perform rapid testing of blood samples for many critical assays, where biosensors are used for drug screening, appropriate measurement of blood cells, detection of cardiac markers and glucose testing.

Global Point-of-Care Diagnostics Market report is segmented on the testing, by mode, end-users and by regional & country level. Based upon testing, global point-of-care diagnostics market is segmented as glucose testing, infectious disease, blood gas electrolyte, cardiac biomarker, coagulation, cholesterol, pregnancy, drugs of abuse, urinalysis, and hematology and other. Furthermore, based upon mode, point-of-care diagnostics market is segmented into prescription-based testing and OTC-based testing. Based on end-users, market is classified into hospitals and clinics, homecare settings and diagnostic centers.

The regions covered in this Point-of-Care Diagnostics market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Point-of-Care Diagnostics market is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Report Analysis Details
Historical data 2015 - 2020
Forecast Period 2021 - 2027
Market Size in 2018: USD 22688.6 Million
Base year considered 2020
Forecast Period CAGR %:

10.73 %

Market Size Expected in 2025: USD 46308.9 Million
Tables, Charts & Figures: 175
Pages 200
Key Players/Companies Abbott Laboratories, Becton Dickinson & Co, Bio-Rad Laboratories, Inc., Trinity Biotech, Quidel, Danaher, F. Hoffmann-La Roche Ltd, Nova Biomedical, Siemens Healthcare AG, bioMerieux SA, Zoetis, Inc., Instrumentation Laboratory, Trividia Health, Inc., Sekisui Diagnostics, Spectral Medical, Inc., and others. 
Segments Covered By Testing, By Mode, By End-Users
Regional Analysis North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Key Players for Point-of-Care Diagnostics Market Report–

Some major key players for global Point-of-Care Diagnostics market are

  • Abbott Laboratories
  • Becton Dickinson & Co
  • Bio-Rad Laboratories
  • Trinity Biotech
  • Quidel
  • Danaher
  • Hoffmann-La Roche Ltd
  • Nova Biomedical
  • Siemens Healthcare AG
  • bioMerieux SA
  • Zoetis
  • Instrumentation Laboratory
  • Trividia Health
  • Sekisui Diagnostics
  • Spectral Medical
  • others

Rising incidences of chronic diseases such as diabetes, cancer and increasing geriatric population are expected to drive the Point-of-Care Diagnostics Market growth.

Point-of-care diagnostics market is expected to show a high growth owing to the rising demand of home based healthcare devices collectively on account of providing rapid test results for positive health outcome of patients. In addition, in time sensitive medical conditions, POCD devices provide requirements along with cost effective test procedure, timely medical care for ambulatory patients which create the immense demand of these types of medical solutions. Furthermore, patient’s inclination towards early detection of chronic diseases as well as rising geriatric population are also supplementing the demand for point of care diagnostics devices with immediate test results made positive outlook in healthcare delivery. Globally, aged population over 60 years was 962 million in 2017; the number of older population is expected to reach around 2.1 billion by 2050. For example, i-STAT System offers most comprehensive testing solutions include cardiac markers, blood gases, lactate, chemistries and electrolytes, coagulation, and hematology. Diabetes covers nearly 67% of POCD market. However, before consideration of implementing any point of care device, regulatory requirements should be performed that arise as a biggest challenge for the further growth of this market. Untapped potential of lab on chip technology will create opportunities for future expansion of POCT market.

North America is expected to dominate the Point-of-Care Diagnostics Market.

North America holds largest share of point of care diagnostics market due to the prevalence of chronic diseases such as diabetes, cancer, heart disease, where high incidences of time sensitive medical condition provides encouragement for the expansion of POCT in this region. In 2016, over 1.7 million of people in the U.S. were needed to have a cancer diagnosis. Moreover, favorable government initiatives related to the development of healthcare infrastructure and widespread manufacturers are present in the U.S. are constantly focusing on research and development to create POCD products with advanced technologies are some of the factors anticipated to foster the growth in this market in this region within the forecast period. In addition, diagnostic tests are implemented about 7 billion times each year in the U.S. The point of care diagnostics market in Asia Pacific region is expected to grow rapidly due to the high demand of unmet medical needs, growing medical awareness and rise in economy of countries like India & China.

Point-of-Care Diagnostics Market Segmentation:

By Testing

  • Glucose testing
  • Infectious disease
  • Blood gas electrolyte
  • Cardiac biomarker
  • Coagulation
  • Cholesterol
  • Pregnancy
  • Others

By Mode

  • Prescription-based Testing
  • OTC-based Testing

By End-Users

  • Hospitals and Clinics
  • Homecare Settings
  • Diagnostic Centers

On Special Requirments Point-of-Care Diagnostics Market Report is also available for the below Regions and Countries:

North America

  • U.S.
  • Canada


  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Sweden
  • Netherland
  • Turkey
  • Switzerland
  • Belgium
  • Rest of Europe


  • South Korea
  • Japan
  • China
  • India
  • Australia
  • Philippines
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Rest Of APAC

Latin America

  • Mexico
  • Colombia
  • Brazil
  • Argentina
  • Peru
  • Rest of South America

Middle East and Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest Of MEA

Key Benefits for Point-of-Care Diagnostics Market Reports –

  • Global market report covers in depth historical and forecast analysis.
  • Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global market report helps to identify opportunities in market place.
  • Global market report covers extensive analysis of emerging trends and competitive landscape.